Log in to search using one of your social media accounts:


Prostate cancer is now a bigger killer than breast cancer

More than 11,800 men a year are now killed by the disease in Britain, compared with about 11,400 women dying of breast cancer, placing the disease as the third biggest cancer killer.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

AbstractIn Australia, one in two men and one in three women will be diagnosed with cancer by the age of 85. Several studies have demonstrated a decline in the number of medical graduates having examined cancer patients during their training. The aim of this study was to evaluate the exposure of medical students to cancer patients during clinical placements. Eighty-eight logbooks (response rate  = 24.75%) containing 9430 patients were analysed. A total of 829 patients (8.79%) had a diagnosis of cancer. Most cancer patients were seen on surgical placements, whilst general practice placements returned the lowest...
Source: Journal of Cancer Education - Category: Cancer & Oncology Source Type: research
Google (NSDQ:GOOG) this week presented initial data from a prototype augmented reality microscope platform it’s developing for advanced cancer detection, according to a research blog post from the tech giant. The platform consists of a modified light microscope for real-time image analysis and presents analysis from a machine-learning algorithm directly into the users field of view, Google said. Google said the platform could be retrofitted into existing light microscopes generally used in hospitals and clinics using low-cost, readily-available components without the need for digital versions of the scopes. The ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Imaging Research & Development google Source Type: news
In this study, we investigated the role of 4-MU in mammary carcinoma cells with distinct malignant phenotypes and estrogen receptor (ER) status, a major prognostic factor in the clinical management of breast cancers. We focused on two breast cancer cell lines, the low metastatic and ERα+ MCF-7 cells, and the highly-aggressive and ERα- MDA-MB-231 cells. Treatment with 4-MU caused a dose-dependent decrease of hyaluronan accumulation in the extracellular matrix as well as within the breast cancer cells, most prevalent in cells lacking ERα. This decrease in hyaluronan was accompanied by suppression of Hyaluro...
Source: Matrix Biology - Category: Molecular Biology Authors: Tags: Matrix Biol Source Type: research
This article summarizes the approaches to fundamental, translational, clinical, and public health issues in cancer health disparities discussed at the conference. PMID: 29643743 [PubMed]
Source: Journal of Carcinogenesis - Category: Cancer & Oncology Tags: J Carcinog Source Type: research
Conclusions Independent trials indicate that the PMR–GI combination is an effective way to tackle the impact of nausea and vomiting and to improve patients’ mental state. However, studies involving other types of primary tumors would be useful because seven of the eight clinical trials only included breast cancer patients. Future research on the identification of potential effects on disease-related parameters (e.g., cytokines and disease-recurrence) and on patient survival is highly needed.
Source: EXPLORE: The Journal of Science and Healing - Category: Complementary Medicine Source Type: research
Authors: Wang Y, Lan GB, Peng FH, Xie XB Abstract Renal transplantation is associated with an increased risk of cancers at multiple sites; however, the relationships between increased cancer risk and participant characteristics remain unclear. We searched PubMed, Embase, and the Cochrane Library to identify prospective observational studies performed up to July 2017. Totally 11 prospective studies reported data on 79,988 renal transplant recipients were included. Renal transplant recipients were found to display a higher risk of all cancers (standard incidence ratio [SIR]: 2.89; 95% CI: 2.13-3.91; P
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
CONCLUSIONS: Our data demonstrated that GDF15 promoted the proliferation of cervical cancer cells via the up-regulation of CyclinD1 and CyclinE1 and the down-regulation of p21 through both the PI3K/AKT and MAPK/ERK signaling pathways in a complex with ErbB2. PMID: 29636108 [PubMed - in process]
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Tags: J Exp Clin Cancer Res Source Type: research
The extra money a year will take annual research spending to £40million – roughly the amount invested in breast cancer research, which has long had an advantage.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
The extra money a year will take annual research spending to £40million – roughly the amount invested in breast cancer research, which has long had an advantage.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Project will see 40,000 men recruited for research into the disease, which kills more than 11,000 a yearThe prime minister is to launch a new drive against prostate cancer, which kills more than 11,000 men every year in the UK and causes great anxiety and sometimes suffering for the 47,000 men who get a diagnosis.Theresa May will announce £75m for research that will recruit 40,000 men into trials for better diagnosis and treatments for the disease, whichrecently overtook breast cancer to become the third biggest cancer killer in the UK. That is partly down to earlier detection and better treatment of breast cancer, a...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Theresa May Cancer research Health Medical research Science Politics UK news Prostate cancer Society Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | Prostate Cancer | UK Health | Women